The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback